2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

SEARCH RESULTS

BROWSE BY PROGRAM

Discover abstracts and sessions by meeting track.

Search Criteria: Program: Poster Abstract Session
231 Sessions
Saturday, December 12, 2026 77 Sessions
05:30 p.m. - 07:30 p.m. 101. Red Cells and Erythropoiesis, Excluding Iron: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 102. Iron Homeostasis and Biology in Physiological and Pathological Conditions: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 112. Thalassemia and Globin Gene Regulation: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 113. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Basic and Translational: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 114. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 201. Granulocytes, Monocytes, and Macrophages: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 301. Platelets and Megakaryocytes: Basic and Translational: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 321. Coagulation and Fibrinolysis: Basic and Translational: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 322. Hemophilia A and B: Clinical and Epidemiological: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 323. Disorders of Coagulation, Bleeding, or Fibrinolysis, Excluding Congenital Hemophilias: Clinical and Epidemiological: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 330. Vascular Biology, Thrombosis, and Thrombotic Microangiopathies: Basic and Translational: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 331. Thrombotic Microangiopathies/Thrombocytopenias: Clinical and Epidemiological: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 332. Thrombosis and Anticoagulation: Clinical and Epidemiological: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 401. Blood Transfusion: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 501. Hematopoietic Stem and Progenitor Cells and Hematopoiesis: Basic and Translational: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 503. Clonal Hematopoiesis, Aging, and Inflammation: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 506. Bone Marrow Microenvironment: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 508. Bone Marrow Failure: Acquired: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 509. Bone Marrow Failure and Cancer Predisposition Syndromes: Congenital: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 602. Myeloid Oncogenesis: Basic: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 603. Lymphoid Oncogenesis: Basic: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 604. Molecular Pharmacology and Drug Resistance: Myeloid Neoplasms: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 605. Molecular Pharmacology and Drug Resistance: Lymphoid Neoplasms: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 612. Acute Lymphoblastic Leukemias: Clinical and Epidemiological: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 613. Acute Lymphoblastic Leukemias: Therapies Excluding Allogeneic Transplantation: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 614. Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers, and Measurable Residual Disease in Diagnosis and Prognosis: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 615. Acute Myeloid Leukemias: Clinical and Epidemiological: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 616. Acute Myeloid Leukemias: Investigational Drug and Cellular Therapies: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 617. Acute Myeloid Leukemias: Commercially Available Therapies: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 618. Acute Myeloid Leukemias: Biomarkers and Molecular Markers in Diagnosis and Prognosis: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 619. Acute Myeloid Leukemias: Disease Burden and Measurable Residual Disease in Prognosis and Treatment: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 621. Lymphomas: Translational: Molecular and Genetic: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 622. Lymphomas: Translational – Non-Genetic: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 623. Mantle Cell, Follicular, Waldenstrom’s, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 624. Hodgkin Lymphomas: Clinical and Epidemiological: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 625. T Cell, NK Cell, or NK/T Cell Lymphomas: Clinical and Epidemiological: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 626. Aggressive Lymphomas: Epidemiological Excluding Prospective Clinical Trials: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 627. Aggressive Lymphomas: Targeted and Pharmacologic Therapies: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 628. Aggressive Lymphomas: Cellular Therapies: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 629. Aggressive Lymphomas, Non-Cellular Immunotherapy Including Bispecific Antibodies: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 632. Chronic Myeloid Leukemia: Clinical and Epidemiological: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 634. Myeloproliferative Syndromes: Clinical and Epidemiological: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

Description

Outstanding mix of clinical abstracts, including clinical trials, retrospective analysis, and molecular observations in myelofibrosis, polycythemia vera, essential thrombocythemia and other myeloid neoplasms

05:30 p.m. - 07:30 p.m. 636. Myelodysplastic Syndromes: Basic and Translational: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 637. Myelodysplastic Syndromes: Clinical and Epidemiological: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 641. Chronic Lymphocytic Leukemia: Basic and Translational: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 642. Chronic Lymphocytic Leukemia: Clinical and Epidemiological: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 651. Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 652. MGUS, Amyloidosis, and Other Non-Myeloma Plasma Cell Dyscrasias: Clinical and Epidemiological: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 653. Multiple Myeloma: Clinical and Epidemiological: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 654. Multiple Myeloma: Pharmacologic Therapies: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 655. Multiple Myeloma: Cellular Therapies: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 656. Multiple Myeloma: Biomarkers in Diagnosis, Prognosis, and Treatment Outcome, Including Minimal Residual Disease: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 701. Experimental Transplantation: Basic and Translational: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 702. CAR-T Cell Therapies: Basic and Translational: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 703. Cellular Immunotherapies Other Than CAR-T Cells: Basic and Translational: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 704. Cellular Immunotherapies: Early Phase Clinical Trials and Toxicities: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 711. Cell Collection and Manufacturing of HSPCs, CAR-T Cells, and Other Cellular Therapy Products: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 721. Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 722. Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 723. Allogeneic Transplantation: Long-term Follow-up, Complications, and Disease Recurrence: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 732. Allogeneic Transplantation: Disease Response and Comparative Treatment Studies: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 801. Gene Therapies: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 802. Chemical Biology and Experimental Therapeutics: Harnessing Chemical Biology to Reveal Therapeutic Vulnerabilities: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 803. Emerging Tools, Techniques, and Artificial Intelligence in Hematology: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 900. Health Services and Quality Improvement: Hemoglobinopathies: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 901. Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 902. Health Services and Quality Improvement: Lymphoid Malignancies: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 903. Health Services and Quality Improvement: Myeloid Malignancies: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 904. Outcomes Research: Hemoglobinopathies: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 906. Outcomes Research: Lymphoid Malignancies Excluding Plasma Cell Disorders: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 907. Outcomes Research: Plasma Cell Disorders: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 908. Outcomes Research: Myeloid Malignancies: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

05:30 p.m. - 07:30 p.m. 909. Medical Education and Workforce Development: Poster I Program: Poster Abstract Session
Location

MCCNO - Hall F

Sunday, December 13, 2026 77 Sessions
06:00 p.m. - 08:00 p.m. 101. Red Cells and Erythropoiesis, Excluding Iron: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 102. Iron Homeostasis and Biology in Physiological and Pathological Conditions: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 112. Thalassemia and Globin Gene Regulation: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 113. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Basic and Translational: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 114. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 201. Granulocytes, Monocytes, and Macrophages: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 301. Platelets and Megakaryocytes: Basic and Translational: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 321. Coagulation and Fibrinolysis: Basic and Translational: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 322. Hemophilia A and B: Clinical and Epidemiological: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 323. Disorders of Coagulation, Bleeding, or Fibrinolysis, Excluding Congenital Hemophilias: Clinical and Epidemiological: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 330. Vascular Biology, Thrombosis, and Thrombotic Microangiopathies: Basic and Translational: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 331. Thrombotic Microangiopathies/Thrombocytopenias: Clinical and Epidemiological: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 332. Thrombosis and Anticoagulation: Clinical and Epidemiological: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 401. Blood Transfusion: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 501. Hematopoietic Stem and Progenitor Cells and Hematopoiesis: Basic and Translational: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 503. Clonal Hematopoiesis, Aging, and Inflammation: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 506. Bone Marrow Microenvironment: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 508. Bone Marrow Failure: Acquired: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 509. Bone Marrow Failure and Cancer Predisposition Syndromes: Congenital: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 602. Myeloid Oncogenesis: Basic: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 603. Lymphoid Oncogenesis: Basic: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 604. Molecular Pharmacology and Drug Resistance: Myeloid Neoplasms: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 605. Molecular Pharmacology and Drug Resistance: Lymphoid Neoplasms: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 612. Acute Lymphoblastic Leukemias: Clinical and Epidemiological: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 613. Acute Lymphoblastic Leukemias: Therapies Excluding Allogeneic Transplantation: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 614. Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers, and Measurable Residual Disease in Diagnosis and Prognosis: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 615. Acute Myeloid Leukemias: Clinical and Epidemiological: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 616. Acute Myeloid Leukemias: Investigational Drug and Cellular Therapies: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 617. Acute Myeloid Leukemias: Commercially Available Therapies: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 618. Acute Myeloid Leukemias: Biomarkers and Molecular Markers in Diagnosis and Prognosis: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 619. Acute Myeloid Leukemias: Disease Burden and Measurable Residual Disease in Prognosis and Treatment: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 621. Lymphomas: Translational – Molecular and Genetic: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 622. Lymphomas: Translational – Non-Genetic: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 623. Mantle Cell, Follicular, Waldenstrom’s, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 624. Hodgkin Lymphomas: Clinical and Epidemiological: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 625. T Cell, NK Cell, or NK/T Cell Lymphomas: Clinical and Epidemiological: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 626. Aggressive Lymphomas: Epidemiological Excluding Prospective Clinical Trials: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 627. Aggressive Lymphomas: Targeted and Pharmacologic Therapies: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 628. Aggressive Lymphomas: Cellular Therapies: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 629. Aggressive Lymphomas, Non-Cellular Immunotherapy including Bispecific Antibodies: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 632. Chronic Myeloid Leukemia: Clinical and Epidemiological: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 634. Myeloproliferative Syndromes: Clinical and Epidemiological: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 636. Myelodysplastic Syndromes: Basic and Translational: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 637. Myelodysplastic Syndromes: Clinical and Epidemiological: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 641. Chronic Lymphocytic Leukemia: Basic and Translational: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 642. Chronic Lymphocytic Leukemia: Clinical and Epidemiological: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 651. Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 652. MGUS, Amyloidosis, and Other Non-Myeloma Plasma Cell Dyscrasias: Clinical and Epidemiological: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 653. Multiple Myeloma: Clinical and Epidemiological: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 654. Multiple Myeloma: Pharmacologic Therapies: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 655. Multiple Myeloma: Cellular Therapies: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 656. Multiple Myeloma: Biomarkers in Diagnosis, Prognosis, and Treatment Outcome, including Minimal Residual Disease: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 701. Experimental Transplantation: Basic and Translational: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 702. CAR-T Cell Therapies: Basic and Translational: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 703. Cellular Immunotherapies other than CAR-T Cells: Basic and Translational: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 704. Cellular Immunotherapies: Early Phase Clinical Trials and Toxicities: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 711. Cell Collection and Manufacturing of HSPCs, CAR-T Cells, and Other Cellular Therapy Products: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 721. Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 722. Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 723. Allogeneic Transplantation: Long-term Follow-up, Complications, and Disease Recurrence: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 732. Allogeneic Transplantation: Disease Response and Comparative Treatment Studies: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 801. Gene Therapies: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 802. Chemical Biology and Experimental Therapeutics: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 803. Emerging Tools, Techniques, and Artificial Intelligence in Hematology: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 900. Health Services and Quality Improvement: Hemoglobinopathies: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 901. Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 902. Health Services and Quality Improvement: Lymphoid Malignancies: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 903. Health Services and Quality Improvement: Myeloid Malignancies: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 904. Outcomes Research: Hemoglobinopathies: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 906. Outcomes Research: Lymphoid Malignancies Excluding Plasma Cell Disorders: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 907. Outcomes Research: Plasma Cell Disorders: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 908. Outcomes Research: Myeloid Malignancies: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 909. Medical Education and Workforce Development: Poster II Program: Poster Abstract Session
Location

MCCNO - Hall F

Monday, December 14, 2026 77 Sessions
06:00 p.m. - 08:00 p.m. 101. Red Cells and Erythropoiesis, Excluding Iron: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 102. Iron Homeostasis and Biology in Physiological and Pathological Conditions: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 112. Thalassemia and Globin Gene Regulation: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 113. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Basic and Translational: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 114. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 201. Granulocytes, Monocytes, and Macrophages: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 301. Platelets and Megakaryocytes: Basic and Translational: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 321. Coagulation and Fibrinolysis: Basic and Translational: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 322. Hemophilia A and B: Clinical and Epidemiological: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 323. Disorders of Coagulation, Bleeding, or Fibrinolysis, Excluding Congenital Hemophilias: Clinical and Epidemiological: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 330. Vascular Biology, Thrombosis, and Thrombotic Microangiopathies: Basic and Translational: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 331. Thrombotic Microangiopathies/Thrombocytopenias: Clinical and Epidemiological: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 332. Thrombosis and Anticoagulation: Clinical and Epidemiological: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 401. Blood Transfusion: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 501. Hematopoietic Stem and Progenitor Cells and Hematopoiesis: Basic and Translational: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 503. Clonal Hematopoiesis, Aging, and Inflammation: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 506. Bone Marrow Microenvironment: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 508. Bone Marrow Failure: Acquired: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 509. Bone Marrow Failure and Cancer Predisposition Syndromes: Congenital: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 602. Myeloid Oncogenesis: Basic: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 603. Lymphoid Oncogenesis: Basic: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 604. Molecular Pharmacology and Drug Resistance: Myeloid Neoplasms: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 605. Molecular Pharmacology and Drug Resistance: Lymphoid Neoplasms: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 612. Acute Lymphoblastic Leukemias: Clinical and Epidemiological: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 613. Acute Lymphoblastic Leukemias: Therapies Excluding Allogeneic Transplantation: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 614. Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers, and Measurable Residual Disease in Diagnosis and Prognosis: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 615. Acute Myeloid Leukemias: Clinical and Epidemiological: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 616. Acute Myeloid Leukemias: Investigational Drug and Cellular Therapies: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 617. Acute Myeloid Leukemias: Commercially Available Therapies: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 618. Acute Myeloid Leukemias: Biomarkers and Molecular Markers in Diagnosis and Prognosis: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 619. Acute Myeloid Leukemias: Disease Burden and Measurable Residual Disease in Prognosis and Treatment: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 621. Lymphomas: Translational – Molecular and Genetic: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 622. Lymphomas: Translational – Non-Genetic: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 623. Mantle Cell, Follicular, Waldenstrom’s, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 624. Hodgkin Lymphomas: Clinical and Epidemiological: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 625. T Cell, NK Cell, or NK/T Cell Lymphomas: Clinical and Epidemiological: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 626. Aggressive Lymphomas: Epidemiological Excluding Prospective Clinical Trials: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 627. Aggressive Lymphomas: Targeted and Pharmacologic Therapies: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 628. Aggressive Lymphomas: Cellular Therapies: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 629. Aggressive Lymphomas, Non-Cellular Immunotherapy including Bispecific Antibodies: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 632. Chronic Myeloid Leukemia: Clinical and Epidemiological: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 634. Myeloproliferative Syndromes: Clinical and Epidemiological: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 636. Myelodysplastic Syndromes: Basic and Translational: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 637. Myelodysplastic Syndromes: Clinical and Epidemiological: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 641. Chronic Lymphocytic Leukemia: Basic and Translational: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 642. Chronic Lymphocytic Leukemia: Clinical and Epidemiological: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 651. Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 652. MGUS, Amyloidosis, and Other Non-Myeloma Plasma Cell Dyscrasias: Clinical and Epidemiological: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 653. Multiple Myeloma: Clinical and Epidemiological: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 654. Multiple Myeloma: Pharmacologic Therapies: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 655. Multiple Myeloma: Cellular Therapies: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 656. Multiple Myeloma: Biomarkers in Diagnosis, Prognosis, and Treatment Outcome, including Minimal Residual Disease : Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 701. Experimental Transplantation: Basic and Translational: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 702. CAR-T Cell Therapies: Basic and Translational: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 703. Cellular Immunotherapies other than CAR-T Cells: Basic and Translational: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 704. Cellular Immunotherapies: Early Phase Clinical Trials and Toxicities: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 711. Cell Collection and Manufacturing of HSPCs, CAR-T Cells, and Other Cellular Therapy Products: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 721. Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 722. Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 723. Allogeneic Transplantation: Long-term Follow-up, Complications, and Disease Recurrence: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 732. Allogeneic Transplantation: Disease Response and Comparative Treatment Studies: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 801. Gene Therapies: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 802. Chemical Biology and Experimental Therapeutics: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 803. Emerging Tools, Techniques, and Artificial Intelligence in Hematology: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 900. Health Services and Quality Improvement: Hemoglobinopathies: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 901. Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 902. Health Services and Quality Improvement: Lymphoid Malignancies: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 903. Health Services and Quality Improvement: Myeloid Malignancies: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 904. Outcomes Research: Hemoglobinopathies: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 906. Outcomes Research: Lymphoid Malignancies Excluding Plasma Cell Disorders: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 907. Outcomes Research: Plasma Cell Disorders: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 908. Outcomes Research: Myeloid Malignancies: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F

06:00 p.m. - 08:00 p.m. 909. Medical Education and Workforce Development: Poster III Program: Poster Abstract Session
Location

MCCNO - Hall F